159 related articles for article (PubMed ID: 34407395)
1. Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection.
Parent AV; Faleo G; Chavez J; Saxton M; Berrios DI; Kerper NR; Tang Q; Hebrok M
Cell Rep; 2021 Aug; 36(7):109538. PubMed ID: 34407395
[TBL] [Abstract][Full Text] [Related]
2. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
3. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
4. Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation.
Ajith A; Mulloy LL; Musa MA; Bravo-Egana V; Horuzsko DD; Gani I; Horuzsko A
Front Immunol; 2021; 12():687715. PubMed ID: 34177940
[TBL] [Abstract][Full Text] [Related]
5. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.
Gornalusse GG; Hirata RK; Funk SE; Riolobos L; Lopes VS; Manske G; Prunkard D; Colunga AG; Hanafi LA; Clegg DO; Turtle C; Russell DW
Nat Biotechnol; 2017 Aug; 35(8):765-772. PubMed ID: 28504668
[TBL] [Abstract][Full Text] [Related]
6. Generation of universal and hypoimmunogenic human pluripotent stem cells.
Ye Q; Sung TC; Yang JM; Ling QD; He Y; Higuchi A
Cell Prolif; 2020 Dec; 53(12):e12946. PubMed ID: 33174655
[TBL] [Abstract][Full Text] [Related]
7. Immune-evasive human islet-like organoids ameliorate diabetes.
Yoshihara E; O'Connor C; Gasser E; Wei Z; Oh TG; Tseng TW; Wang D; Cayabyab F; Dai Y; Yu RT; Liddle C; Atkins AR; Downes M; Evans RM
Nature; 2020 Oct; 586(7830):606-611. PubMed ID: 32814902
[TBL] [Abstract][Full Text] [Related]
8. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
Flahou C; Morishima T; Takizawa H; Sugimoto N
Front Immunol; 2021; 12():662360. PubMed ID: 33897711
[TBL] [Abstract][Full Text] [Related]
9. Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers.
Pizzato HA; Alonso-Guallart P; Woods J; Connelly JP; Fehniger TA; Atkinson JP; Pruett-Miller SM; Monsma FJ; Bhattacharya D
Stem Cell Reports; 2024 Feb; 19(2):299-313. PubMed ID: 38215755
[TBL] [Abstract][Full Text] [Related]
10. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.
Moretta L; Locatelli F; Pende D; Marcenaro E; Mingari MC; Moretta A
Blood; 2011 Jan; 117(3):764-71. PubMed ID: 20889923
[TBL] [Abstract][Full Text] [Related]
11. Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted β2m-HLA-G fusion proteins.
Shi L; Li W; Liu Y; Chen Z; Hui Y; Hao P; Xu X; Zhang S; Feng H; Zhang B; Zhou S; Li N; Xiao L; Liu L; Ma L; Zhang X
Stem Cells; 2020 Nov; 38(11):1423-1437. PubMed ID: 32930470
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
13. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
[TBL] [Abstract][Full Text] [Related]
15. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
16. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell subsets differentially reject embryonic stem cells based on licensing.
Perez-Cunningham J; Ames E; Smith RC; Peter AK; Naidu R; Nolta JA; Murphy WJ
Transplantation; 2014 May; 97(10):992-8. PubMed ID: 24704665
[TBL] [Abstract][Full Text] [Related]
18. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells.
Flahou C; Morishima T; Higashi N; Hayashi Y; Xu H; Wang B; Zhang C; Ninomiya A; Qiu WY; Yuzuriha A; Suzuki D; Nakamura S; Manz M; Kaneko S; Hotta A; Takizawa H; Eto K; Sugimoto N
Biochem Biophys Res Commun; 2023 Jun; 662():76-83. PubMed ID: 37099813
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
20. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
